Blueprint Medicines Corp 2024年度报告
Annex 1 Socio-Economic Analysis Of the potential restriction of the perand polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products
Disc Medicine Inc美股招股说明书(2025-01-23版)
How Off-Label Use of Medicines Drives Health-Care Use and Disability
Report of the second joint meeting (hybrid) of the WHO Global Advisory Committee on Vaccine Safety and the WHO Advisory Committee on Safety of Medicinal Products, 14–16 December2022
Harnessing the Benefits of Externally Controlled Clinical Trials (ECTs) to Accelerate Development of Better Medicines
3D MEDICINES-B二零二二年年报
3D MEDICINES二零二三年年报
Editas Medicine Inc 2024年度报告
3D MEDICINES二零二三年中期报告
公众号
小程序
社群